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Bovine respiratory disease (BRD) causes substantial morbidity and mortality, affecting
cattle of all ages. One of the main causes of BRD is an initial inflammatory response
to bovine respiratory syncytial virus (BRSV). MicroRNAs are novel and emerging non-
coding small RNAs that regulate many biological processes and are implicated in
various inflammatory diseases. The objective of the present study was to elucidate
the changes in the bovine bronchial lymph node miRNA transcriptome in response
to BRSV following an experimental viral challenge. Holstein-Friesian calves were either
administered a challenge dose of BRSV (103.5 TCID50/ml × 15 ml) (n = 12) or were
mock inoculated with sterile phosphate buffered saline (n = 6). Daily scoring of clinical
signs was performed and calves were euthanized at day 7 post-challenge. Bronchial
lymph nodes were collected for subsequent RNA extraction and sequencing (75 bp).
Read counts for known miRNAs were generated using the miRDeep2 package using
the UMD3.1 reference genome and the bovine mature miRNA sequences from the
miRBase database (release 22). EdgeR was used for differential expression analysis
and Targetscan was used to identify target genes for the differentially expressed (DE)
miRNAs. Target genes were examined for enriched pathways and gene ontologies using
Ingenuity Pathway Analysis (Qiagen). Multi-dimensional scaling (MDS) based on miRNA
gene expression changes, revealed a clearly defined separation between the BRSV
challenged and control calves, although the clinical manifestation of disease was only
mild. One hundred and nineteen DE miRNAs (P < 0.05, FDR < 0.1, fold change > 1.5)
were detected between the BRSV challenged and control calves. The DE miRNAs
were predicted to target 465 genes which were previously found to be DE in bronchial
lymph node tissue, between these BRSV challenged and control calves. Of the DE
predicted target genes, 455 had fold changes that were inverse to the corresponding
DE miRNAs. There were eight enriched pathways among the DE predicted target genes
with inverse fold changes to their corresponding DE miRNA including: granulocyte
and agranulocyte adhesion and diapedesis, interferon signalling and role of pathogen
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recognition receptors in recognition of bacteria and viruses. Functions predicted to be
increased included: T cell response, apoptosis of leukocytes, immune response of cells
and stimulation of cells. Pathogen recognition and proliferation of cytotoxic T cells are
vital for the recognition of the virus and its subsequent elimination.
Keywords: miRNA, small RNA-Seq, dairy calves, pneumonia, bovine respiratory disease, BRSV challenge
INTRODUCTION
The majority of morbidity and mortality reported in calves
between 1 and 6 months of age is associated with bovine
respiratory disease (BRD) (Taylor et al., 2010; Curtis et al., 2016;
Johnston et al., 2016; Murray et al., 2017). The causes of BRD
are multifactorial, including infectious viral and bacterial agents,
host genetics, farm management, and husbandry practices,
environmental stressors including severe weather conditions
and the interactions between these factors (Taylor et al., 2010).
Viruses are generally the initiators of BRD and the resulting
damage they inflict on the respiratory tract predisposes calves to
secondary infections through the proliferation and colonisation
of bacteria which generally comprise the normal flora of the
upper respiratory tract (Johnston et al., 2017).
Bovine respiratory syncytial virus (BRSV) is an enveloped,
non-segmented, negative-stranded RNA virus of the
Orthopneumovirus genus from the family Pneumoviridae,
and is one of the leading infectious viral causes of BRD
(Valarcher and Taylor, 2007; Rima et al., 2017; Sudaryatma
et al., 2018). Morbidity resulting from BRSV infections ranges
from 60 to 80%, and mortality has been reported to reach
20% during disease outbreaks (Valarcher and Taylor, 2007).
BRSV can manifest as sub-clinical or can induce severe clinical
signs including coughing, nasal discharge, pyrexia, anorexia
and increased respiratory rates (Valarcher and Taylor, 2007).
Infection with BRSV leads to the initiation of the inflammatory
cytokine response, with increases in several cytokines including
IFNγ, IL-12β, IL-6, TNF, IL-18, CXCL8, CCL3, CCL5, CCL2,
IFNα1, and IFNβ1, and the subsequent influx of leukocytes,
predominantly neutrophils, produces inflammation and lung
pathology (Valarcher and Taylor, 2007; Sudaryatma et al., 2018).
BRSV is capable of interfering with the host’s anti-viral interferon
based response and inducing immunomodulation by shifting the
adaptive immune response towards a Th2 dominated response,
rather than an effective cytotoxic cell mediated response, which
enables establishment and maintenance of the virus (Gershwin,
2007; Valarcher and Taylor, 2007).
Although susceptibility to BRD is moderately heritable
(Neibergs et al., 2014), there is limited literature describing the
molecular level immune response of the bovine to infection
with pathogenic agents of the bovine respiratory disease complex
(BRDC), including BRSV. Two RNA-Seq studies of crossbred
Angus-Hereford beef calves, conducted in the United States,
examined the differentially expressed (DE) genes and pathways
in bronchial lymph node (Tizioto et al., 2015) and in multiple
lymphoid and lung tissues (Behura et al., 2017) following
experimental challenge with single pathogens of the BRDC.
Our group has reported 934 genes to be DE in the bronchial
lymph node of Irish Holstein-Friesian calves in response to a
BRSV challenge (Johnston et al., 2019). However, no studies
have been performed to date to elucidate the micro (mi) RNA
transcriptional response to an experimental BRSV challenge in
calves. Micro RNAs are short, single-stranded, endogenous, non-
coding RNA molecules (21–25 nucleotides in length) which are
involved in the regulation of gene expression as they trigger the
degradation or repress the translation of their target messenger
(m) RNAs by directly binding to their 3′ untranslated regions
(UTR) (Wahid et al., 2010). Tissue specific miRNA profiles can
be altered following infection by various viral and bacterial agents
(Lawless et al., 2014; Luoreng et al., 2018). The objective of this
study was to elucidate the miRNAs and their target genes involved
in the bovine bronchial lymph node transcriptome response to
an experimental viral challenge with BRSV in artificially-reared
dairy bull calves. These DE miRNAs, and in particular, their
target genes which were found to be DE in our previous study




The animal model has previously been described (Johnston
et al., 2019). Briefly, Holstein-Friesian bull calves with low BRSV
maternally derived antibodies and a negative BRSV PCR result
(mean age 143 ± 14 days, mean weight 155 ± 14 kg) were
either challenged with 103.5 TCID50/ml × 15 ml inoculum of
BRSV strain SVA 274/9220 (Graham et al., 1999) (n = 12; BRSV
challenged) or were mock challenged with sterile phosphate
buffered saline (PBS) (n = 6; control), by aerosol inhalation, at
the Agri-Food Biosciences Institute (AFBI), Stormont, Northern
Ireland. Clinical signs including nasal discharge, ocular discharge,
general appearance, coughing, respiratory rate and character,
size of mandibular lymph nodes, presence or absence of
mouth breathing or an expiratory grunt, dyspnoea, and rectal
temperature, were recorded daily from the day of challenge until
euthanasia, and subsequently scored by a veterinarian (blinded
to the calves’ BRSV challenged or control treatment status),
using a previously described clinical scoring system (Johnston
et al., 2019). Calves were euthanized by captive bolt 7 days post
challenge. The lungs were examined and scored for percentages
of lesions on the total lung area and on component lung parts,
using an AFBI standardised lung scoring system, by a trained
veterinarian, as described in Johnston et al. (2019).
Bleach, 75% ethanol and RNaseZap were used to disinfect
and remove contaminant RNA/DNA from the work surfaces and
implements before tissue collection for each animal. Bronchial
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lymph node tissues were collected and immediately flash frozen
in liquid nitrogen, placed on dry ice and subsequently stored in
an−80◦C freezer.
RNA Extraction
The Qiagen RNeasy Plus Universal Mini Kit (Qiagen Ltd.,
Manchester, United Kingdom), was used according to the
manufacturer’s instructions (including Appendix C of the
manufacturer’s protocol), for extraction of total RNA (including
miRNAs). The quantity and quality of the extracted RNA
was determined by measuring the absorbance at 260 nm
with a Nanodrop spectrophotometer (NanoDrop technologies;
Wilmington, DE, United States) and by using the RNA 6000 Nano
LabChip kit (Agilent Technologies Ireland Ltd., Dublin, Ireland)
with the Agilent 2100 Bioanalyser (Agilent Technologies Ireland
Ltd., Dublin, Ireland). The mean RNA Integrity Number of the
samples was 8.6± 0.31.
Library Preparation and Sequencing
Extracted RNA was shipped frozen at −80◦C on dry ice to
the University of Missouri’s DNA Core Facility for miRNA
sequencing library preparation using the TruSeq Small RNA
Library Prep Kit (Illumina, San Diego, CA, United States),
according to manufacturer’s instructions, and high-throughput
sequencing (75 bp) was performed on an Illumina NextSeq 500.
Bioinformatics and Differential miRNA
Expression Analysis
Sequence reads (FASTQ format) were assessed for quality using
FastQC (version 0.11.7)1. The 3′ ends of the sequence reads
were trimmed to remove bases with quality scores less than 20
and (because of artefacts of the NextSeq technology) artificial
poly-Gs using cutadapt version 1.18 (Martin, 2011). Reads
which contained fewer than 15 bases, greater than 30 bases,
or ambiguous nucleotides (N’s) were discarded. Contaminant
short RNA sequences including transfer RNAs, ribosomal RNAs,
small nucleolar RNAs, and small nuclear RNAs2 were removed
using Bowtie version 1.2.2 (Langmead et al., 2009). The cleaned
sequence reads were analysed for quality metrics using FastQC
(version 0.11.7) and all reads passed the basic quality statistics.
Read counts for known miRNAs were generated using
the miRDeep2 package (version 2.00.8) (Friedlander et al.,
2012) using the UMD3.1 bovine reference genome and the
bovine mature and precursor miRNA sequences from the
miRBase database (release 22) (Griffiths-Jones et al., 2008).
Sequence reads were initially pre-processed (parsed to fasta
format, sequences with non-canonical letters discarded, any
possible remaining 3′ adapters clipped, short reads discarded),
collapsed into clusters and aligned with Bowtie (Langmead
et al., 2009) to the indexed UMD3.1 reference genome,
using the mapper module (mapper.pl) with default parameters.
Subsequently, the miRDeep2 module (miRDeep2.pl) (with
default parameters) was used to quantify bovine miRNAs,
with Bos taurus defined as the species of interest, and with
1http://www.bioinformatics.babraham.ac.uk/projects/fastqc/
2Downloaded from https://rnacentral.org/
the collapsed reads vs. reference genome alignments, bovine
mature miRNA sequences, bovine precursor miRNA sequences
(including the hairpin structures) and the human mature miRNA
sequences, as input files.
Differential gene expression was determined using the R
[R version 3.5.2 (2018-12-20)] Bioconductor package EdgeR
(version 3.24.3) (Robinson et al., 2010). This package accounts
for both biological and technical variation and models the data
using a negative binomial distribution. Any genes with less than
one count per million reads in at least six of the samples were
removed from the analysis as lowly expressed genes. The trimmed
mean of M-values normalisation method (Robinson and Oshlack,
2010) was employed to normalise data across libraries. Dispersion
was estimated using both the quantile-adjusted conditional
maximum likelihood (qCML) common dispersion and the qCML
tagwise dispersion. Exact tests were used for the detection
of DE miRNAs between the BRSV challenged and control
calves. MiRNAs with a Benjamini–Hochberg false discovery rate
(FDR) < 0.1 and a fold change of ≥1.5 were considered DE.
Target Gene Prediction
Target genes for the DE miRNAs were predicted using
the Targetscan 7.0 Perl scripts (Agarwal et al., 2015)
downloaded from http://www.targetscan.org/cgi-bin/targetscan/
data_download.vert72.cgi. Targetscan_70.pl was used to
predict both conserved and non-conserved miRNA target
sites using a file containing all known gene transcripts
3′ UTR sequence alignments and the miRNA family
information file, as input files. Targetscan_70_BL_bins.pl
and targetscan_70_BL_PCT.pl were used to calculate branch
lengths and the probability of conservation of target sites.
Finally, targetscan_70_context_scores.pl and RNAplfold from
ViennaRNA version 2.1.13 were used to calculate the miRNA
target genes’ context + + scores.
Pathway and Functional Enrichment
Analysis
The predicted target genes of the DE miRNAs, which were
expressed in the bronchial lymph node tissues of the calves
had a context ++ percentile rank of 99 and were used for
pathway and functional enrichment. Additionally, the predicted
target genes for the DE miRNAs which were observed to
be DE in the bronchial lymph nodes between the BRSV
challenged and control calves with an FDR of <0.1 and a
fold change of >2 in the previous study (Johnston et al.,
2019) and which had an inverse fold change to that of their
miRNA target, were examined for enriched pathways, cellular,
and molecular functions and predicted upstream regulators
using the Ingenuity Pathway Analysis (IPA) (QIAGEN Inc.3),
according to the manufacturer’s instructions (Krämer et al.,
2014). Identification of over-represented pathways and over-
represented molecular and cellular functions was accomplished
using Fisher’s exact test, with Benjamini–Hochberg multiple
testing correction. The regulation Z-score algorithm within IPA,
which predicts increases or decreases in functions based on
3https://www.qiagenbioinformatics.com/products/ingenuitypathway-analysis
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the directional differential expression of genes and expectations
derived from the literature, was utilised to predict differences in
the over-represented cellular and molecular functions. Cellular
and molecular functions with a regulation Z-score value of ≥2.0
were predicted to be significantly increased and cellular and
molecular functions with a regulation Z-score value of ≤−2.0
were predicted to be significantly decreased by the IPA software.
RESULTS
Clinical Scores and Lung Pathology
Clinical respiratory sign scoring and lung pathology assessments
were performed and results were previously reported in detail
in Johnston et al. (2019). Briefly, there were no significant
differences in clinical scores between the BRSV challenged and
the control calves at any of the time-points (P > 0.05), analysed
with a repeated measures mixed model procedure in SAS v 9.4.
Furthermore, a mixed model ANOVA analysis also performed
using SAS v 9.4 indicated that lung scores did not differ between
BRSV challenged and control calves (P > 0.05). However, the
probability of having a lesioned lung was greater for the BRSV
challenged than the control calves (P = 0.04), determined using
a Fisher’s exact test in SAS v 9.4. Lesions were only found on the
lungs of one of the control calves, whereas nine of the 12 BRSV
challenged calves presented with lung lesions.
Sequence Alignment
An average of 5,002,047 sequence reads per library was received
in FASTQ format. Approximately 2,525,780 reads remained,
on average; following trimming with cutadapt and an average
of 2,170,434 reads were retained following filtering of reads
containing contaminant short RNA species. Following MirDeep2
pre-processing, an average of 2,093,463 sequence reads remained
for mapping (Supplementary Table 1). Eighty-eight percent of
reads were mapped to the UMD3.1 bovine reference genome
(Supplementary Table 1).
Differential MiRNA Expression
A multi-dimensional scaling (MDS) plot was generated in
EdgeR which plotted samples on a two dimensional space
based on global miRNA expression, using the first two principal
components. A clearly defined separation between the BRSV
challenged and the control calves was visible in the MDS plot
(Figure 1). There were 119 DE miRNAs (p < 0.05, FDR < 0.1,
fold change > 1.5) between the BRSV challenged and control
calves (Supplementary Table 2). Sixty-seven miRNAs were up-
regulated and 52 were down-regulated in the BRSV challenged
calves relative to the control calves.
Target Genes and Functional Annotation
of Target Genes
Targetscan predicted that 6,892 of the 13,909 genes which were
expressed in the bronchial lymph nodes of these calves (Johnston
et al., 2019) were targeted by the 119 DE miRNAs. Of these
target mRNA genes, 3,410 had a weighed context + + score
FIGURE 1 | An MDS plot generated in EdgeR illustrating the similarity of the
samples based on the Log2 miRNA gene expression covariance matrix
among individuals. Samples from BRSV challenged calves are coloured in red
and samples from control calves are coloured in blue. The numbers (1–18)
refer to the calf identifier and the letter S in front of the numbers refers to the
word “sample.”
percentile of 99% (Supplementary Table 3). The predicted
target genes with a weighed context + + score percentile
of 99% of the top ten most significant DE miRNAs are
presented in Table 1. The predicted target genes with a weighed
context + + score percentile of 99% were subsequently analysed
for pathway and functional enrichment within IPA. There
were 120 enriched pathways among the predicted target genes
in the 99th percentile rank of weighted context + + score
(FRD < 0.1) (Supplementary Table 4). The most significant
of the enriched pathways were associated with IL-8 signalling,
cell regulation, apoptosis and cell proliferation (Table 2). There
were 500 enriched diseases and functions (FDR < 0.1), and
these were related to cell death and survival, inflammation and
differentiation (Supplementary Table 5).
The DE miRNAs were predicted by Targetscan to target 465
genes which were previously found to be DE in bronchial lymph
node tissue, between these BRSV challenged and control calves
(Johnston et al., 2019). Of the DE predicted target genes, 455 had
inverse fold changes to that of the corresponding DE miRNAs
(Supplementary Table 6). Ingenuity pathway analysis showed
that eight pathways were enriched (FDR < 0.1) among the
DE predicted target genes with inverse fold changes to those
of the corresponding DE miRNAs including: granulocyte and
agranulocyte adhesion and diapedesis, interferon signalling and
role of pathogen recognition receptors in recognition of bacteria
and viruses (Figure 2 and Supplementary Table 7). Interferon
signalling, oestrogen-mediated S-phase entry, BAG2 signalling
and LXR/RXR were predicted by IPA to be up-regulated
(Z-Score ≥ 2) (Figure 2). The up-regulated genes within the
interferon signalling pathway and the down-regulated miRNAs
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TABLE 1 | The predicted target genes with a weighed context ++ score percentile of 99% of the top ten most significant differentially expressed miRNAs.
miRNA P-value FDR Fold
change
Gene targets
bta-miR-10164-3p 1.38E-58 6.63E-56 7.75 SFRP1, MRPL51, CD302, CHIC2, DARS1, PGPEP1, SDC2, FAM241A, RTKN2, EFCAB11, ACER2,
SLC25A26, MYOZ1, LPGAT1, PFDN4, SH3BGRL, CAMK2N1, CENPP, KLF9, PPP2R2A, UBTD2, PERP,
SYPL1, VPS29, ISCA2, ETFA, ACYP2
bta-miR-21-3p 1.08E-50 2.60E-48 3.65 TIMM21, ECT2, ACVR1B, SPRING1, FGF2, TSPAN3, SLC7A11, LSM11, TGFA, ZNF22, NDRG2, TRUB1,
PCLAF, SDC2, MPLKIP, FBXO22, ARHGAP12, LYPLA1, C10H14orf119, PAK2, CISD1, HOMER1, NR4A2,
RTN3, TUBD1, SKP1, PPTC7, ZBTB14, ATP2B1, PDLIM5, RASSF9, ZBTB41, LMO4, FBXO36, RAB14,
TMEM170B, BCL7C, RDH11, PDE1A, ATP13A3, ETF1, MGAT4D, SNAP91, BCL7A, NUDT3
bta-miR-107 2.11E-27 3.39E-25 2.04 ST13, ATP5F1E, CAB39, RNF38, CBLN3, TMEM47, GPR15, HPGDS, EIF5A2, BIRC5, NUDCD2, EMB,
PLEKHF2, SLC25A5, ZNRF2, SUSD6, DICER1, ACVR2B, TMEM170A, PDLIM5, PPP1R15B, ARMT1,
STX7, GOPC, AFG1L, SMNDC1, UBE2A, RRAGC, NIPSNAP3A, NTRK2, ANGPTL7, C8H9orf40, NDUFB6,
NLN, EID2, ZHX1, PKIA, STXBP6, PDE7A, CPEB3, SMIM13, LRRC34, SEPTIN5, USF3, LAMTOR3,
DDAH1, DNAJC3
bta-miR-11971 8.00E-25 9.62E-23 3.18 UBR7, TOMM22, XBP1, CCL22, VPS18, YAE1, NDUFS1, ATP5F1E, CAPNS1, TSPAN3, ESCO1, POLR3K,
SLC25A34, ELP6, NUDT21, MSL2, RFFL, OPA3, NFAM1, SOCS3, EFNA5, AP3S2, CMTR2, TMEM167B,
SYDE2, SLC20A2, DYNLRB1, EMP2, SPOUT1, TMEM183A, RABIF, HECA, RNGTT, UBL4A, SLC30A7,
TACR2, ROMO1, SLC31A1, TBXA2R, SMIM5, EXT1, C13H20orf96, PSMB9, PKIA, SNX20, BLOC1S3,
C28H10orf105, PCP4L1, KLHL3, BCL7A
bta-miR-15a 8.24E-23 7.93E-21 1.90 CCND1, ASF1A, GPR63, NEK9, YIPF4, NAA50, PRKAB2, RNF144B, RNF138, ARL1, TTC19, SMAD7,
MOB3B, N4BP1, FGF2, MGAT4A, PIP4P2, NMNAT2, TRUB1, SPRED1, TRIM35, TMEM192, SULT1B1,
CDK5R1, IL20RA, PLAG1, FIBIN, PAGR1, ZNF704, RFLNB, PRMT3, SLC20A2, STX7, GNAI3, DR1,
MIGA1, PLPP3, SLC35G1, PPP1R11, KATNAL1, FGF9, TBX20, TMEM100, EMC1, TMEM167A, RAB30,
GSKIP, DYNLL2, MOB4
bta-miR-30d 9.04E-22 6.21E-20 −1.66 FKBP14, YIPF4, PCNP, TUBD1, MAP3K7, GNG10, CAMK2N1, SPIN1, MINDY3, FAM126B, NSG1,
PLEKHM3, TMEM107, LSM5, TRIQK, BICD1
bta-miR-141 9.03E-22 6.21E-20 2.64 KRR1, NUDCD1, NFYB, TMX4, CCNB1, SPRING1, AP5M1, STX2, CHIC2, HPS3, OSBPL11, PGRMC2,
LSM1, PLAG1, SOBP, VPS37A, C20H5orf22, YAF2, C9H6orf120, CISD1, HORMAD2, IGF1, BRI3BP,
SERPINC1, RIT1, TENT5C, DR1, SAR1A, REEP3, UBE2D1, ZDHHC21, EID2, TIA1, TMEM107, MEGF10,
UBE2V2, RBM7, VTI1B
bta-miR-339a 5.85E-18 3.52E-16 −1.69 ALKBH1, BRMS1L, EGLN3, FDXACB1, BCAT1, CRISPLD2, ANKIB1, IGFBP4, FSTL1, PGRMC2, SPTSSA,
C9H6orf120, EFNA5, ABRACL, DR1, METTL8, C8H9orf64, APTX, C28H10orf105, RWDD1, MGAT4D,
DYNLL2
bta-miR-744 1.05E-17 5.62E-16 −2.34 TMOD2, MRPL35, SH3BGRL3, PPIC, PRMT9, C25H16orf54, MRTO4, SOX18, MANBAL, PLA2G2D4,
SMIM5, CENPP, TNFRSF9, LY86, FAXC, C22H3orf18, ABHD14B, RBPMS2, RAB31
bta-miR-502b 3.70E-17 1.78E-15 −2.40 CHODL, NAA35, LYPD1, PAFAH1B2, RTCA, TRAM1, FAM219A, EIF2B2, HDAC2, SERBP1, SPOPL,
ADSS2, CDYL2, IL6ST, BUB3, C11H2orf68, RAP2A, VAMP4, GATAD1, ENDOD1, DYNLL2, SLC7A11,
SLC17A5, SMIM13, ADPRM
targeting these genes are presented in Figure 3 and Table 3.
There were 500 enriched diseases and functions (FDR < 0.1), and
21 of these functions were predicted by IPA’s regulation Z-score
algorithm to be increased (including cell survival, lymphocyte
response, T cell response and cell death) (Z-Score≥ 2) while four
were predicted to be decreased (including morbidity or mortality)
(Z-Score ≤−2) (Supplementary Table 8).
DISCUSSION
To our knowledge, this is the first study to examine the
miRNA transcriptional response in calves to challenge with
BRSV. The BRSV experimental challenge induced large changes
in miRNA transcription with 119 DE miRNA in bronchial
lymph node tissue in BRSV challenged compared to control
Holstein-Friesian calves. Micro-RNAs are involved in the post
transcriptional regulation of biological responses (Wahid et al.,
2010) and in innate and adaptive immune mechanisms (Inui
and Martello, 2010; O’Connell et al., 2010; Vegh et al., 2013).
They play an important regulatory role in the global translation
of genes into proteins as they can reduce levels of mRNA by
initiating its degradation or they may prevent its translation
(Wahid et al., 2010). They have been implicated in bovine
disease conditions, host immune responses to pathogens and
environmental challenge. For example, the miRNA profile of dry
secretions up to 21 days post dry-off has been characterised in
pregnant multi-parous Holstein cows, and changes in miRNA
expression over-time were associated with pregnancy, lactation,
inflammation and disease (Putz et al., 2019). Additionally,
twenty-seven miRNAs were identified to be DE between
mammary tissues of Holstein cattle experiencing heat stress and
normal conditions (Li et al., 2018).
Several studies have reported changes in the expression
of bovine miRNAs due specifically to disease status. Twenty-
five miRNAs were DE in milk from Holstein Friesian cows
infected with mastitis relative to milk from healthy Holstein
Friesian cows (Lai et al., 2020). Furthermore, members of the
BRDC have been observed to induce miRNA transcriptional
alterations including a change in abundance of two miRNAs
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TABLE 2 | Top enriched pathways among the predicted target genes in the 99th
percentile rank of weighted context ++ score.
Ingenuity canonical pathways −log10 (B-H p-value)
Unfolded protein response 3.83
IL-8 signalling 2.24
Molecular mechanisms of cancer 2.24
Cell cycle regulation by BTG family proteins 2.24
fMLP signalling in neutrophils 2.21
Cardiac hypertrophy signalling 2.21
PI3K/AKT signalling 2.21




Cyclins and cell cycle regulation 2.08
IGF-1 signalling 2.08
TGF-β signalling 2.08
Hypoxia signalling in the cardiovascular system 2.05
Glioma invasiveness signalling 2.01
Breast cancer regulation by stathmin1 1.98
in serum, due to a bovine viral diarrhoea virus challenge
in colostrum deprived, neonate, Holstein calves (Taxis et al.,
2017), and variations in the concentrations of four miRNAs
associated with a serum antibody response, which indicated
exposure to mycoplasma, in beef cattle (Casas et al., 2016).
However, while these studies show the involvement of miRNA
in multifactorial aspects of animal health, there is no published
literature detailing any alterations in transcription of miRNAs
due to a specific viral challenge with BRSV, one of the main
viral causes of BRD.
Understanding the changes in abundance of miRNAs during
an experimental challenge with BRSV leads to important
insights into the host transcriptional and regulatory response
to infection. BRSV replicates in ciliated airway epithelial
cells and type 2 pneumocytes and induces the expression of
host pro-inflammatory cytokines which recruit neutrophils and
lymphocytes to the lung and causes bronchiolitis and interstitial
pneumonia (Guzman and Taylor, 2015). The observed changes
in host miRNA abundance induced by the BRSV challenge
demonstrates that miRNAs play a role in the recognition of
BRSV and the instigation of the host pro-inflammatory anti-
viral state during infection with BRSV. This is evident due
to an enrichment of specific pathways and functions among
the predicted target genes of the DE miRNA. These include
Toll-like receptor signalling, IL-8 signalling, apoptosis signalling,
role of MAPK signalling in the pathogenesis of Influenza,
JAK/Stat signalling, NF-kB signalling, T cell receptor signalling,
chemokine signalling, apoptosis, cell death of lung cells, T cell
development, and antiviral response of T lymphocytes.
In the current study, the miRNAs which were DE in response
to the BRSV challenge infection targeted 455 genes which were
DE in the bronchial lymph node of these calves (Johnston
et al., 2019) and which had inverse fold changes to those of
the DE miRNA. Since the miRNAs reduce the concentration
and/or the level of translation of their target mRNA transcripts,
the DE miRNAs whose fold changes are inversely related to
the fold changes of their target DE mRNAs show a consistent
functional response outcome and therefore are the most relevant
FIGURE 2 | The enriched canonical pathways found in the IPA analysis (P < 0.05, FDR < 0.1) among the DE predicted target genes with inverse fold changes to
those of the corresponding DE miRNAs. The pathways are shown on the x-axis and the –Log10 Benjamini–Hochberg adjusted p values are displayed on the y-axis.
The threshold is set to one which equals a Benjamini–Hochberg adjusted p value of 0.1. Pathways with a positive z-score are predicted by IPA to have increased
activity and pathways with a negative z-score are predicted to have decreased activity.
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FIGURE 3 | A Venn diagram (Husen et al., 2008) portraying the DE (up-regualted) genes causing the up-regulation of the interferon signalling pathway in the BRSV
challenged calves and the number of their targeting DE (down-regulated) miRNAs.
TABLE 3 | The DE genes within the enriched up-regulated interferon signalling pathway and their DE targeting miRNAs.
DE Gene Targeting DE miRNA
BAK1 bta-miR-328, bta-miR-504, bta-miR-199b, bta-miR-628, bta-miR-31, bta-miR-148b, bta-miR-6119-3p, bta-miR-95, bta-miR-301a, bta-miR-185,
bta-miR-11999, bta-miR-2313-3p, bta-miR-2284w, bta-miR-339a, bta-miR-491, bta-miR-11989, bta-miR-296-3p, bta-miR-2435, bta-miR-1271,
bta-miR-183, bta-miR-34b, bta-miR-1249, bta-miR-34c, bta-miR-340, bta-miR-153, bta-miR-2346, bta-miR-744, bta-miR-2415-3p,
bta-miR-30b-3p, bta-miR-1343-3p, and bta-miR-7180.
IFIT1 bta-miR-148b, bta-miR-2313-3p, bta-miR-129, bta-miR-129-5p, bta-miR-139, bta-miR-183, bta-miR-153, and bta-miR-1296.
IFIT3 bta-miR-6119-3p, bta-miR-2284w, bta-miR-183, bta-miR-2346, bta-miR-502b, bta-miR-30b-3p, and bta-miR-11998.
IFNγ bta-miR-328, bta-miR-301a, bta-miR-129, bta-miR-129-5p, bta-miR-183, bta-miR-2284v, and bta-miR-2284d.
OAS1 bta-miR-328, bta-miR-129, bta-miR-129-5p, bta-miR-183, and bta-miR-1343-3p.
The DE genes were all up-regulated in the bronchial lymph node of the BRSV challenged calves and the DE targeting miRNAs were all down-regulated.
target mRNAs of the DE miRNAs. These target genes were
involved in the recognition of BRSV by pathogen recognition
receptors, granulocyte and agranulocyte adhesion, and diapedesis
and interferon signalling. These enriched pathways among
the DE predicted target genes of the DE miRNA show that
miRNAs are important in the transcriptional response to BRSV
infection and that the response is broadly similar to that
of the host response to human respiratory syncytial virus
(HRSV) which is primarily associated with the activation of
interferon gamma associated signalling pathways (Vieira et al.,
2019) and recruitment of cytotoxic T cells which are capable
of destroying virus infected cells and resolving the infection
(Griffiths et al., 2017). Furthermore, the host immune response,
including the production of pro-inflammatory cytokines and the
influx of neutrophils, natural killer cells and cytotoxic T cells, are
responsible for the majority of respiratory tissue pathology, rather
than virus replication (Griffiths et al., 2017). However, the virus
causes some cytopathology, including in bronchial epithelial cells,
through the creation of intracytoplasmic inclusion bodies and
large multinucleated syncytial cells (Griffiths et al., 2017).
Calves are natural hosts for BRSV, the BRSV calf challenge
infection is also considered to be a model system for HRSV
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infection in infants (Guzman and Taylor, 2015; Zhang et al.,
2017). HRSV is an important cause of respiratory disease
mortality in children younger than 5 years of age (Scheltema
et al., 2017). Globally, HRSV is responsible for the deaths of
approximately 60,000 children aged younger than 5 years, per
annum (Battles and McLellan, 2019). BRSV and HRSV use their
non-structural proteins to supress their host’s induction of an
anti-viral type 1 interferon (IFN) response (Guzman and Taylor,
2015). They accomplish this through interference with IFN signal
transduction by decreasing the levels of STAT2 (Ramaswamy
et al., 2004; Janssen et al., 2007) and inhibiting the activation and
nuclear translocation of IFN regulatory factor 3 (Spann et al.,
2005). They also use their G and small hydrophobic proteins
to evade the host’s innate and acquired immune responses
(Guzman and Taylor, 2015), including interference with Toll like
receptor signalling (Moore et al., 2008), promotion of a Th2
primed response (Griffiths et al., 2017), the down-regulation of
expression of IFNβ and ISG15 (Moore et al., 2008), induction
of SOCS protein expression (Moore et al., 2008; Bakre et al.,
2012; Zheng et al., 2015) and inhibition of TNF-α signalling
(Fuentes et al., 2007). However, we (Johnston et al., 2019)
and others (Janssen et al., 2007) have shown that even though
BRSV and HRSV can suppress the type 1 interferon anti-viral
host response, the host is still capable of mounting a primarily
Th1 skewed, interferon dominated, transcriptional immune
response, due to the up-regulation of IFN-γ and of interferon
stimulated genes. The present study further emphasises the
importance of interferon signalling in the host response to BRSV
as interferon signalling was predicted to be up-regulated in
response to the BRSV experimental challenge among the DE
miRNA target genes. Additionally, it highlights an important
role of miRNAs in regulating and augmenting the interferon
anti-viral response.
In the current study, 39 miRNAs involved in the regulation
of the interferon response to BRSV were discovered. Of these
DE miRNAs, several of them targeted multiple up-regulated
genes involved in the interferon response. miR-183 targeted
IFNγ, IFIT, IFIT3, BAK1 while OAS1, miR-328, and miR-129-
5p targeted IFNγ, BAK1, and OAS1, mir-129 targeted IFNγ,
IFIT1, and OAS1, miR-1343-3p targeted BAK1 and OAS1, miR-
301a targeted BAK1 and IFNγ, miR-2284w and miR-30b-3p
targeted BAK1 and IFIT3, and miR-148b, miR-2313-3p, and miR-
153 targeted BAK1 and IFIT1. Interestingly, these DE miRNAs
were all down-regulated, while all their targets were up-regulated.
Therefore, these miRNAs are likely involved in regulating the
interferon response and a decrease in expression of these miRNAs
is conceivably responsible for the increased expression of these
genes (IFNγ, IFIT, IFIT3, BAK1, and OAS1) involved in the
interferon response.
Although there are no published studies to-date detailing
the miRNA transcriptional response to BRSV, there are several
studies describing changes in miRNA abundances due to HRSV
infection, including the up-regulation of the miRNAs; let-7f,
miR-24, miR-337-3p, miR-26b, and miR-520a-5p, and the down-
regulation of miR-198 and miR-595, in vitro, in a human
alveolar epithelial cell line (Bakre et al., 2012). However, the
majority of changes in miRNA expression induced by HRSV
described in published studies (Leon-Icaza et al., 2019) were not
observed in this study. Indeed, several in vitro studies have found
members of the miR-30 family to be up-regulated in response
to HRSV infection (Wu et al., 2020) whereas in this current
study, miR-30b-3p, miR-30d, miR-30f, and miR-30c, were down-
regulated in bovine bronchial lymph node tissue following the
in vivo experimental challenge with BRSV. A possible reason
for the inconsistencies observed between changes in expression
of miRNAs due to BRSV in this study and previous HRSV
studies, may be that this study examined changes in bronchial
lymph node tissue from calves while the other studies were
performed using cell lines or cultured primary or dendritic cells,
in vitro (Bakre et al., 2012; Thornburg et al., 2012; Leon-Icaza
et al., 2019). Interestingly, miR-139 was similarly down-regulated
in human bronchial epithelial cell culture due to infection
with HRSV (Othumpangat et al., 2012) as in bronchial lymph
node tissue due to the BRSV challenge in this present study.
Additionally, changes in expression of miR-30d, miR-34b, and
miR34c, were consistent between this study and a study which
found that these three miRNAs had reduced expression in nasal
mucosa from HRSV clinically-infected infant patients compared
to healthy controls (Inchley et al., 2015). Furthermore, these
three miRNAs were also down-regulated in airway bronchial
epithelial cell brushings from asthmatic adult patients (Solberg
et al., 2012), which supports their potential importance in
respiratory health.
Currently, there are no licenced vaccines for HRSV, despite
more than 50 years of research into potential candidate vaccines
(Atherton et al., 2019). Furthermore, despite the existence of
several vaccines targeting BRSV since the 1970s, there is a lack of
evidence supporting their efficacy in reducing disease incidence
or morbidity or mortality (Ellis, 2017). Therefore, knowledge of
potential miRNA biomarkers of BRSV based on the host response
to challenge infections as in the current study may be beneficial
for predicting vaccine candidate outcomes. Furthermore, the
development of new therapeutic anti-viral treatments targeting
miRNAs which stimulate the pro-inflammatory response would
be beneficial as damage induced by the host’s own immune
response causes the majority of BRSV induced pathologies
observed in respiratory tissues (Valarcher and Taylor, 2007).
The miRNAs involved in the bovine bronchial lymph node
response to BRSV elucidated in this study could, following
further validation, possibly be used as new diagnostic tools
for BRSV since the differently abundant miRNAs may act as
biomarkers of BRSV disease exposure. This novel form of
diagnostic assay would be particularly useful since BRSV can
often present as sub-clinical disease, as was evidenced in the
present study. However, despite the observation of only a mild
clinical response to BRSV infection in the current study, there
were large changes in both mRNA and miRNA transcription
in the bronchial lymph node of calves responding to the BRSV
challenge. Therefore, the DE miRNAs and the DE mRNAs
observed in this study and the previous study (Johnston et al.,
2019), could potentially be used to develop a novel diagnostic test
for BRSV before full symptoms of the disease manifest.
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The miRNAs involved in the calves’ bronchial lymph
node global transcriptomic regulatory response to BRSV, and
their target genes, likely harbour variants which influence
susceptibility to BRD. The identification of microRNAs changed
in the challenged BRSV calf model will help to elucidate the
complex inflammatory response in BRD and should contribute
to our understanding of its pathogenesis. The DE miRNA
and their target genes could be interrogated further in large
scale longitudinal studies where calves acquire BRD either
through natural infection or experimental challenge with other
BRD causing pathogens. Following validation, variants in
these DE miRNAs and their target genes could be included
in genomic selection breeding programmes to contribute to
the breeding of healthier cattle with improved resistance to
BRD. In conclusion, this is the first report on the miRNA
expression profile in BRSV challenged calves and may provide
a basis for revealing the regulatory mechanism of BRSV
infection and the potential role of miRNAs as biomarkers
of BRD diagnosis.
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